SCHEMBL5301320

SCHEMBL5301320

O=C(O)CC(c1ccccc1)n1cnc2ccc(NC(=O)c3cc(Cl)cc(Cl)c3O)cc21

nearest known ligand 0.49

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.49
TBXAS1 P24557 1/20 0.49
MAPK1 P28482 1/20 0.49
PTGS2 P35354 1/20 0.49
MAPK14 Q16539 1/20 0.49
STK39 Q9UEW8 13/20 0.48
PARG Q86W56 3/20 0.48
CTSD P07339 2/20 0.44
PNLIP P16233 1/20 0.43
NR2E3 Q9Y5X4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5288993 0.93 PTGS1 (0.49) PTGS1TBXAS1MAPK1PTGS2MAPK14
SCHEMBL2297569 0.88 TMPRSS4 (0.49)
SCHEMBL2294406 0.86 HSD17B13 (0.38)
SCHEMBL2295598 0.85 MEN1 (0.43) PNLIP
SCHEMBL2293976 0.84 PTGDR2 (0.42)
SCHEMBL2295055 0.84 KDR (0.47)
SCHEMBL2294478 0.83 NPC1 (0.48) MAPK1
SCHEMBL2296479 0.83 NPC1 (0.39)
SCHEMBL2297504 0.82 FFAR1 (0.48) MAPK1
SCHEMBL2294479 0.82 FADS1 (0.46) PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828144-A2 INTEGRIN ANTAGONISTS USEFUL AS ANTICANCER AGENTS OSI Pharmaceuticals, Inc. (US) 2007-09-05 EP claimed
WO-2006053342-A2 INTEGRIN ANTAGONISTS USEFUL AS ANTICANCER AGENTS OSI PHARMACEUTICALS, INC. (US) 2006-05-18 WO claimed